07.05.2012

MagForce to Present at Entry & General Standard Conference 2012 in Frankfurt

Berlin, Germany, May 07, 2012 – MagForce AG (Frankfurt, XETRA: MF6), a leading medical technology company in the field of nanomedicine for oncology, announced today that Dr Andreas Jordan, Executive Board, will deliver a presentation on the Company at the Entry & General Standard Conference 2012, Frankfurt, Germany. Dr Jordan will talk about the current status of MagForce as well as the business strategy and commercialization of its NanoTherm® therapy. Also, Dr Jordan will give an outlook on the rest of 2012. 

The presentation takes place on Tuesday, May 08, 2012, at 10:45 CET in the Nanotechnology Forum (Room: Liberty I).

MagForce recently announced their restructuring and focused corporate strategy and the hiring of Christian von Volkmann, former CFO of Jerini AG, as Head of Finance.

Disclaimer
This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce AG may substantially differ from these forward-looking statements. MagForce AG assumes no obligation to update these forward-looking statements or to correct them in case of developments, which differ from those, anticipated.

Contact:
Anne Hennecke
MC Services AG

T +49 89 210228-18
F +49 89 210228-88
M +49 151 12 555 759
Email: anne.hennecke@mc-services.eu